Skinvive for Neck Lines: What the FDA Approved, and What It Did Not
On June 11, 2026, the FDA approved Skinvive by Juvéderm to reduce neck lines in adults over the age of 21. It is the first injectable approved to reduce neck lines, and it is not the first injectable approved for the neck.
Plenty of people are happy with their face and wish the neck would keep pace, so this one landed with a stir. Allergan Aesthetics announced the approval five days later. If you have read about Skinvive before, it was almost certainly about cheeks, which is what it was approved for in 2023. That one's the glow story: our guide to Skinvive as a skin booster is all cheeks. The neck is a different treatment with a different rulebook.
What did the FDA approve?
The approved indication reads:
SKINVIVE by JUVÉDERM® is indicated for intradermal injection to improve skin smoothness of the cheeks and intradermal and/or subdermal injection to reduce neck lines for improvement of neck appearance in adults over the age of 21
In plain language: the hyaluronic acid gel goes into the skin of the neck, or just underneath it, to soften the lines that run across it, in patients over 21. The cheek approval from 2023 is untouched.
The approval does not cover loose or sagging neck skin. The manufacturer's directions also state that safety and effectiveness for other areas of the body have not been established, so the cheeks and the neck are where it has been tested.
Is this the first injectable approved for the neck?
No. Botox Cosmetic got there first.
It is already approved for moderate to severe platysma bands, the vertical cords that stand out down the front of the neck when you tense it. Those cords are a muscle pulling, so a muscle relaxer is the tool. More on our Botox page.
Skinvive is approved for the horizontal lines, the ones that ring the neck like rings on a tree. Those are a skin problem, not a muscle problem, and a gel in the skin is a different tool.
Does Skinvive treat "tech neck"?
"Tech neck" is what people call those horizontal lines, and it's what most of us type into a search bar. It is not an FDA term, it does not appear on the label, and the approval says nothing about what put the lines there.
What's been measured is age. In one published comparison of 77 people in three age groups, the elasticity of neck skin, how bouncy it stays when pulled, fell from about 75 percent in the youngest to about 56 percent in the oldest, and firmness with it.
Neck skin is thin, it moves all day, and it gives up its spring early. If you've started tipping your chin up for photos, you're not imagining it.
Skinvive is approved to reduce the lines, whatever put them there. You don't need a theory about your phone to qualify.
What the study showed, and who was not in it
The approval rests on one randomized study: 159 people at 13 sites, 105 treated and 54 left untreated for six months, with the doctor who graded the results kept blind to who got what.
At one month, 74.8 percent of the treated group had improved by at least one grade on the Allergan Transverse Neck Lines Scale, a five-grade scale, against 16.1 percent of the untreated group. Both figures include a statistical estimate standing in for people who missed a visit. At six months, 66.0 percent still held that improvement, against 9.1 percent of the untreated group.
Side effects are common, and mostly things you see rather than things you treat. Nearly nine in ten people had at least one reaction where the injections went in: redness in 82 percent, bruising in 78 percent, tenderness in 78 percent, small lumps or bumps in 76 percent, most of them mild and gone within two weeks. Adverse events the investigators tied to the treatment itself were rarer, at 3.4 percent, all mild, all resolved, with no deaths and no serious treatment-related events.
Plan for a visible week, and possibly two visits: Allergan's directions describe an optional touch-up about 30 days later, and the typical total they give for the neck, 3.0 mL, counts it in.
Of the 105 people treated in that study, 12 had skin the investigators graded as Fitzpatrick type V or VI, the two deepest tones on the scale clinicians use. Allergan states that the neck treatment has not been studied in darker skin tone patients, and twelve people is too few to argue with that. It's a gap in what has been measured rather than a finding of harm, and it's worth raising with whoever would be treating you. Our providers would rather have that conversation than skip past it.
Why you may not be able to book it in Denver yet
The approval came with a condition attached, the kind Allergan says the FDA applies to some novel products. The company has to build a training program specific to this device, covering anatomy and blood vessels, injection technique, and how to manage complications including a blocked blood vessel. It may only sell to providers who complete it.
The order gives Allergan six months from June 11 to get it running. Allergan has said it expects the neck indication to be broadly available later in 2026.
What this looks like at Redbud
At Redbud, Skinvive is already on the injectable menu for the cheeks.
Whether the neck indication is available here yet comes down to that training requirement.
Either way, the consultation is the same. We look at your neck and name what's there, because horizontal lines, loose skin and cords are three different problems that arrive together and don't answer to the same treatment. Smoother skin along the lines is what this one does. It won't tighten a neck, and we'll say so.
The appointment is short. Numbing cream first, until the skin is properly numb, then a row of tiny droplets along the lines with a fine needle, or sometimes a blunt cannula. It feels like quick pinpricks, more odd than sore, and you'll be pink for a few days. Makeup hides a bruise on a cheek more easily than one on the neck, so book well ahead of anything on the calendar.
Nobody here books you for an injectable you don't need. If the answer is to wait, that's what you'll hear. It's a small clinic, warm and unhurried. General questions about first visits, candidacy and recovery live on our FAQ page.
Frequently asked questions
Is Skinvive approved for the lines across my neck, or for the cords?
The lines. The vertical cords that stand out when you tense your neck are a muscle, and Botox Cosmetic is the injectable approved for those. Plenty of people have both, worth sorting out before anyone injects anything.
How long does Skinvive last in the neck?
The study behind the approval followed people for six months. At that mark, 66.0 percent still held at least a one grade improvement, against 9.1 percent of an untreated group. Nothing beyond six months has been measured, so nobody can say what month nine looks like.
Can I get Skinvive for my neck at any med spa?
Not everywhere. The FDA required Allergan to build a training program specific to this device and to sell only to providers who complete it, and to publish a way of checking who has. Any clinic should answer that in a sentence.
Has the neck treatment been studied in darker skin tones?
Not in enough people to say. Twelve of the 105 participants treated had skin graded as Fitzpatrick type V or VI, and Allergan states the neck treatment has not been studied in darker skin tone patients. That is a gap in what has been measured, not a sign of a problem.
If you'd like to talk your neck through with someone, book a consultation, or call or text the clinic at 720-593-8844. We'll tell you what we see. Redbud Medical Spa is at 2345 7th St STE 202, Denver, CO 80211.
This article is for general education and is not medical advice. Skinvive by Juvéderm is an FDA-approved injectable gel, indicated for intradermal injection to improve skin smoothness of the cheeks and for intradermal or subdermal injection to reduce neck lines, in adults over the age of 21. Safety and effectiveness for other areas of the body have not been established. Safety has not been studied during pregnancy or breastfeeding, or in people with a history of excessive scarring or pigmentation disorders. The product contains lidocaine. Individual results vary and no outcome can be promised. Talk with a licensed provider about your own skin, your history and your medications before any treatment.
Sources
- FDA, PMA P110033/S099, SKINVIVE by JUVÉDERM, approved June 11, 2026
- FDA, Approval Order letter, P110033/S099 (conditions of approval, including the required training program)
- FDA, Summary of Safety and Effectiveness Data, P110033/S099 (pivotal neck study)
- Allergan Aesthetics, SKINVIVE by JUVÉDERM Directions for Use, 06/2026
- Allergan Aesthetics, news release: FDA approval for the improvement of neck appearance, June 16, 2026
- FDA/DailyMed, BOTOX Cosmetic (onabotulinumtoxinA) prescribing information, Indications and Usage (platysma bands)
- Engerer N, et al. Aging of the Neck Decoded: New Insights for Minimally Invasive Treatments. Aesthetic Plast Surg. 2022;46(4):1698-1705
Aesthetic Nurse Injector at Redbud Medical Spa


